Keywords: positive, results, envivo, evp-6124, massachusetts, usa-based, pharmaceuticals
Positive results for EnVivo's EVP-6124
Article | 26 January 2009
Massachusetts, USA-based EnVivo Pharmaceuticals says that findings from its safety and biomarker study for EVP-6124, a potent specific alpha-7 agonist, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
